Thapsigargin ≥99% (by HPLC)
Supplier: Enzo Life Sciences
Synonyms:
(3S,3aR,4S,6S,6aR,7S,8S,9bS)-6-Acetoxy-4-(butyryloxy)-3,3a-dihydroxy-3,6,9-trimethyl-8-(((Z)-2-methylbut-2-enoyl)oxy)-2-oxo-2,3,3a,4,5,6,6a,7,8,9b-decahydroazuleno[4,5-b]furan-7-yl octanoate
ATPase inhibitor
Cell permeable tumor promoter. Induces the release of intracellular stored Ca2+ without hydrolysis of inositolphospholipids via inhibition of the (sarco)endoplasmatic reticulum Ca2+-ATPase (SERCA) (IC50=30nM). Inhibition of SERCA reveals a significant change in intracellular Ca2+ homeostasis and pH regulation in tumor cells. May be used to distinguish between discrete intracellular Ca2+ pools. Thapsigargin-induced tumor promotion and down regulation of the EGF receptor is independent of PKC activation. Increases Ca2+-dependent Na+ influx in human platelets in a dose-dependent manner. Induces apoptosis. Stimulates nitric oxide (NO) production, contributing to hepatocyte apoptosis.
Formula:
C₃₄H₅₀O₁₂ MW: 650.762 g/mol |
MDL Number:
MFCD00083511 CAS Number: 67526-95-8 |
Learn more
About VWR
Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...